Literature DB >> 29748437

Quantitative competitive allele-specific TaqMan duplex PCR (qCAST-Duplex PCR) assay: a refined method for highly sensitive and specific detection of JAK2V617F mutant allele burdens.

Chia-Chen Hsu1, Cih-En Huang1,2, Yu-Ying Wu1, Yi-Yang Chen1, Jrhau Lung3, Yu-Wei Leu4, Chian-Pei Li1, Hsing-Yi Tsou1, Wei-Hsuan Chuang1, Chang-Hsien Lu1,2, Chih-Cheng Chen5,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29748437      PMCID： PMC6165818          DOI： 10.3324/haematol.2018.187989

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  15 in total

1.  Concordance of assays designed for the quantification of JAK2V617F: a multicenter study.

Authors:  Eric Lippert; François Girodon; Emma Hammond; Jaroslav Jelinek; N Scott Reading; Boris Fehse; Katy Hanlon; Mirjam Hermans; Céline Richard; Sabina Swierczek; Valérie Ugo; Serge Carillo; Véronique Harrivel; Christophe Marzac; Daniela Pietra; Marta Sobas; Morgane Mounier; Marina Migeon; Sian Ellard; Nicolaus Kröger; Richard Herrmann; Josef T Prchal; Radek C Skoda; Sylvie Hermouet
Journal:  Haematologica       Date:  2008-11-10       Impact factor: 9.941

2.  Enhanced Risk for Specific Somatic Myeloproliferative Neoplastic Mutations in Patients with Stroke.

Authors:  Chih-Cheng Chen; Chia-Chen Hsu; Cih-En Huang; Yi-Yang Chen; Jrhau Lung; Hsing-Ying Ho; Chian-Pei Li; Jiann-Der Lee
Journal:  Curr Neurovasc Res       Date:  2017       Impact factor: 1.990

3.  Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence.

Authors:  Giulio Genovese; Anna K Kähler; Robert E Handsaker; Johan Lindberg; Samuel A Rose; Samuel F Bakhoum; Kimberly Chambert; Eran Mick; Benjamin M Neale; Menachem Fromer; Shaun M Purcell; Oscar Svantesson; Mikael Landén; Martin Höglund; Sören Lehmann; Stacey B Gabriel; Jennifer L Moran; Eric S Lander; Patrick F Sullivan; Pamela Sklar; Henrik Grönberg; Christina M Hultman; Steven A McCarroll
Journal:  N Engl J Med       Date:  2014-11-26       Impact factor: 91.245

4.  The effect of long-term ruxolitinib treatment on JAK2p.V617F allele burden in patients with myelofibrosis.

Authors:  Michael Deininger; Jerald Radich; Timothy C Burn; Reid Huber; Dilan Paranagama; Srdan Verstovsek
Journal:  Blood       Date:  2015-07-30       Impact factor: 22.113

5.  Molecular analysis of patients with polycythemia vera or essential thrombocythemia receiving pegylated interferon α-2a.

Authors:  Alfonso Quintás-Cardama; Omar Abdel-Wahab; Taghi Manshouri; Outi Kilpivaara; Jorge Cortes; Anne-Laure Roupie; Su-Jiang Zhang; David Harris; Zeev Estrov; Hagop Kantarjian; Ross L Levine; Srdan Verstovsek
Journal:  Blood       Date:  2013-06-19       Impact factor: 22.113

6.  Molecular diagnosis of the myeloproliferative neoplasms: UK guidelines for the detection of JAK2 V617F and other relevant mutations.

Authors:  Anthony J Bench; Helen E White; Letizia Foroni; Anna L Godfrey; Gareth Gerrard; Susanna Akiki; Abida Awan; Ian Carter; Andrea Goday-Fernandez; Stephen E Langabeer; Tim Clench; Jordan Clark; Paul A Evans; David Grimwade; Anna Schuh; Mary F McMullin; Anthony R Green; Claire N Harrison; Nicholas C P Cross
Journal:  Br J Haematol       Date:  2012-10-11       Impact factor: 6.998

7.  Clonal evolution in UKE-1 cell line leading to an increase in JAK2 copy number.

Authors:  C Buors; N Douet-Guilbert; F Morel; L Lecucq; B Cassinat; V Ugo
Journal:  Blood Cancer J       Date:  2012-04-13       Impact factor: 11.037

8.  Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease.

Authors:  Siddhartha Jaiswal; Pradeep Natarajan; Alexander J Silver; Christopher J Gibson; Alexander G Bick; Eugenia Shvartz; Marie McConkey; Namrata Gupta; Stacey Gabriel; Diego Ardissino; Usman Baber; Roxana Mehran; Valentin Fuster; John Danesh; Philippe Frossard; Danish Saleheen; Olle Melander; Galina K Sukhova; Donna Neuberg; Peter Libby; Sekar Kathiresan; Benjamin L Ebert
Journal:  N Engl J Med       Date:  2017-06-21       Impact factor: 91.245

9.  Quantitative threefold allele-specific PCR (QuanTAS-PCR) for highly sensitive JAK2 V617F mutant allele detection.

Authors:  Giada V Zapparoli; Robert N Jorissen; Chelsee A Hewitt; Michelle McBean; David A Westerman; Alexander Dobrovic
Journal:  BMC Cancer       Date:  2013-04-24       Impact factor: 4.430

10.  JAK2V617F homozygosity drives a phenotypic switch in myeloproliferative neoplasms, but is insufficient to sustain disease.

Authors:  Juan Li; David G Kent; Anna L Godfrey; Harriet Manning; Jyoti Nangalia; Athar Aziz; Edwin Chen; Kourosh Saeb-Parsy; Juergen Fink; Rachel Sneade; Tina L Hamilton; Dean C Pask; Yvonne Silber; Xiaodong Zhao; Cedric Ghevaert; Pentao Liu; Anthony R Green
Journal:  Blood       Date:  2014-04-01       Impact factor: 22.113
View more
  1 in total

1.  The Genomic Landscape in Philadelphia-Negative Myeloproliferative Neoplasm Patients with Second Cancers.

Authors:  Chia-Chen Hsu; Ying-Hsuan Wang; Yi-Yang Chen; Ying-Ju Chen; Chang-Hsien Lu; Yu-Ying Wu; Yao-Ren Yang; Hsing-Yi Tsou; Chian-Pei Li; Cih-En Huang; Chih-Cheng Chen
Journal:  Cancers (Basel)       Date:  2022-07-14       Impact factor: 6.575
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.